Related Experiment Video
Updated: Jun 19, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Concepts in leptin and liver disease
Reda Mohammed El-Badawy1, Abdullah Saeed Al-Ghamdi, Ibrahim Abdulkarim Al-Mofleh
1Department of Medicine, King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia.
Leptin, a hormone regulating appetite and body fat, is increasingly linked to liver diseases like cirrhosis and NASH. Elevated leptin levels are observed in these conditions, highlighting its potential role in liver pathology.
Area of Science:
- Endocrinology
- Hepatology
- Molecular Biology
Background:
- Leptin is a peptide hormone crucial for regulating appetite and body fat mass, primarily acting on the hypothalamus.
- Produced mainly by adipocytes, leptin is also synthesized in other tissues, including the pancreas, placenta, and skeletal muscles.
- Leptin exerts its functions through short and long receptors, with the long form (OB-Rl) mediating its main actions.
Purpose of the Study:
- To explore the emerging role of leptin in the context of liver diseases.
- To review the association between circulating leptin levels and conditions such as cirrhosis, hepatitis C virus (HCV) infection, and non-alcoholic steatohepatitis (NASH).
Main Methods:
- Literature review of published studies investigating leptin levels in liver disease patients.
- Analysis of data linking leptin to pathological conditions in the liver.
Main Results:
- Circulating leptin levels are significantly elevated in patients with liver diseases, including cirrhosis, HCV, and NASH.
- These findings suggest a potential involvement of leptin in the pathogenesis or progression of liver conditions.
Conclusions:
- Leptin's role in liver diseases is an area of growing research interest.
- Elevated leptin levels in liver disease patients warrant further investigation into its specific mechanisms and clinical implications.
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

